⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8232741 | 0.72 | — | — | |
| SCHEMBL21251413 | 0.63 | — | — | |
| SCHEMBL17419323 | 0.63 | — | — | |
| SCHEMBL1654819 | 0.60 | — | — | |
| SCHEMBL12847209 | 0.57 | — | — | |
| SCHEMBL15094440 | 0.56 | — | — | |
| SCHEMBL277574 | 0.56 | — | — | |
| SCHEMBL234117 | 0.54 | — | — | |
| SCHEMBL28526878 | 0.54 | — | — | |
| SCHEMBL27607701 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3885337-A1 | FTO INHIBITORS | National Institute Of Biological Sciences, Beijing (CN) | 2021-09-29 | — | — | EP | disclosed |
| EP-3471727-B1 | CXCR4 INHIBITORS AND USES THEREOF | X4 PHARMACEUTICALS INC (US) | 2020-12-09 | — | — | EP | disclosed |